Activation of yap1 is significantly associated with poor prognosis and cetuximab resistance in colorectal cancer patients

被引：0
|
作者：
Lee, Keun-Wook [1 ]
Lee, Sung Sook [2 ]
Kim, Sang-Bae [2 ]
Park, Yun-Yong [2 ]
Sohn, Bo Hwa [2 ]
Lee, Hyun-Sung [2 ]
Lee, Ju-Seog [2 ]
机构：
[1] Seoul Natl Univ, Bundang Hosp, Songnam, South Korea
[2] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA
来源：
CANCER RESEARCH | 2014年 / 74卷 / 19期
关键词：
D O I：
10.1158/1538-7445.AM2014-4734
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4734
引用
收藏
页数：2
相关论文
共 50 条
  • [31] MPDZ is associated with immune infiltration and regulates migration and invasion by switching YAP1 phosphorylation in colorectal cancer
    Chen, Zhuang
    Ba, Yuhao
    Zhao, Nannan
    Dang, Qin
    Xu, Hui
    Weng, Siyuan
    Zhang, Yuyuan
    Liu, Shutong
    Zuo, Anning
    Han, Xinwei
    Liu, Zaoqu
    CELLULAR SIGNALLING, 2024, 114
  • [32] Activation of YAP1 confers ROS1 inhibitor resistance in ROS1-rearranged lung cancer
    Yamazoe, Masatoshi
    Ozasa, Hiroaki
    Ogimoto, Tatsuya
    Hosoya, Kazutaka
    Ajimizu, Hitomi
    Yasuda, Yuto
    Funazo, Tomoko
    Tsuji, Takahiro
    Yoshida, Hironori
    Sakamori, Yuichi
    Kim, Young Hak
    Hirai, Toyohiro
    CANCER SCIENCE, 2021, 112 : 890 - 890
  • [33] The YAP1/SIX2 axis is required for DDX3-mediated tumor aggressiveness and cetuximab resistance in KRAS-wild-type colorectal cancer
    Wu, De-Wei
    Lin, Po-Lin
    Wang, Lee
    Huang, Chi-Chou
    Lee, Huei
    THERANOSTICS, 2017, 7 (05): : 1114 - 1132
  • [34] Yes-associated protein expression is associated with poor prognosis in patients with colorectal cancer
    Cao, Liyu
    Zhang, Cong
    Wu, Qingqing
    Bai, Zhenzhen
    Chen, Jing
    ONCOLOGY LETTERS, 2021, 22 (03)
  • [35] Activation of YAP1 confers ROS1 inhibitor resistance in ROS1-rearranged lung cancer
    Yamazoe, Masatoshi
    Ozasa, Hiroaki
    Ohgimoto, Tetsuya
    Hosoya, Kazutaka
    Ajimizu, Hitomi
    Funazo, Tomoko
    Yasuda, Yuto
    Tsuji, Takahiro
    Yoshida, Hironori
    Itotani, Ryo
    Sakamori, Yuichi
    Kim, Young Hak
    Toyohiro, Hirai
    CANCER RESEARCH, 2021, 81 (13)
  • [36] High YAP and TEAD4 immunolabelings are associated with poor prognosis in patients with gallbladder cancer
    Kim, Joo Young
    Sung, You-Na
    Hong, Seung-Mo
    APMIS, 2021, 129 (12) : 729 - 742
  • [37] Overexpression of sortilin is associated with 5-FU resistance and poor prognosis in colorectal cancer
    Blondy, Sabrina
    Talbot, Hugo
    Saada, Sofiane
    Christou, Niki
    Battu, Serge
    Pannequin, Julie
    Jauberteau, Marie-Odile
    Lalloue, Fabrice
    Verdier, Mireille
    Mathonnet, Muriel
    Perraud, Aurelie
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2021, 25 (01) : 47 - 60
  • [38] YAP1 mediated CDK6 activation confers radiation resistance in esophageal cancer: rationale for the combination of YAP1 and CDK4/6 inhibitors in EC
    Li, Fan
    Dong, Xiaoquan
    Zhu, Haitao
    Scott, Ailing W.
    Ma, Lang
    Jin, Jiankang
    Estrella, Jeannelyn Santiano
    Skinner, Heath
    Johnson, Randy L.
    Song, Shumei
    Ajani, Jaffer A.
    CANCER RESEARCH, 2017, 77
  • [39] YAP1 activation is associated with the progression and response to immunotherapy of non-muscle invasive bladder cancer
    Baek, Seung-Woo
    Mun, Jeong-Yeon
    Jang, In-Hwan
    Yang, Gi-Eun
    Jeong, Mi-So
    Kim, Seon-Kyu
    Nam, Jong-Kil
    Chu, In-Sun
    Leem, Sun-Hee
    EBIOMEDICINE, 2022, 81
  • [40] Molecular predictors of cetuximab resistance in colorectal cancer patients
    Finocchiaro, G.
    Cappuzz, F.
    Toschi, L.
    Rossj, E.
    Janne, P. A.
    Roncalli, M.
    Ligorio, C.
    Rimassa, L.
    Santoro, A.
    Varella-Garcia, M.
    ANNALS OF ONCOLOGY, 2008, 19 : 141 - 141
12345